皇家华人

header-logo
GettyImages-609179959-hero
headshot

Marcelo C. Pasquini, MD

Professor

view physician profile

Locations

  • Froedtert Hospital
  • Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English, Spanish, Portuguese

Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

Marcelo C. Pasquini, MD, MS, is a Professor of Medicine in the Division of Hematology and Oncology. He completed medical school at the State University of Londrina, Brazil; postgraduate training in Internal Medicine at the University of Miami/Jackson Memorial Hospital; Hematology and Oncology at the University of Utah; and Blood and Marrow Transplantation at the 皇家华人. He received his Masters of Science degree in Epidemiology from the 皇家华人. Dr. Pasquini also serves as Senior Scientific Director for Clinical Trials at the Center for International Blood and Marrow Transplant Research (CIBMTR) where he focuses on clinical research in the field of transplantation.

Research Interests

His medical practice is focused on hematologic malignancies, including multiple myeloma, acute myeloid leukemia, myelodysplasia and the use of blood and marrow transplantation for treatment of these diseases.

Publications

  • (Kean LS, Burns LJ, Kou TD, Kapikian R, Lozenski K, Langston A, Horan JT, Watkins B, Qayed M, Bratrude B, Betz K, Tang XY, Zhang MJ, Connolly SE, Polinsky M, Gavin B, Gomez-Caminero A, Pasquini MC.) Blood. 2024 Oct 24;144(17):1834-1845 PMID: 39028876 PMCID: PMC11530361 SCOPUS ID: 2-s2.0-85202515431 07/19/2024

  • (Atsuta Y, Baldomero H, Neumann D, Sureda A, DeVos JD, Iida M, Karduss A, Purtill D, Elhaddad AM, Bazuaye NG, Bonfim C, De la Camara R, Chaudhri NA, Ciceri F, Correa C, Frutos C, Galeano S, Garderet L, Gonzalez-Ramella O, Greco R, Hamad N, Hazenberg MD, Horowitz MM, Kalwak K, Ko BS, Kodera Y, Koh MB, Liu K, McLornan DP, Moon JH, Neven B, Okamoto S, Pasquini MC, Passweg JR, Paulson K, Rondelli D, Ruggeri A, Seber A, Snowden JA, Srivastava A, Szer J, Weisdorf D, Worel N, Greinix H, Saber W, Aljurf M, Niederwieser D.) Haematologica. 2024 Oct 01;109(10):3282-3294 PMID: 38721749 PMCID: PMC11443380 SCOPUS ID: 2-s2.0-85199142319 05/09/2024

  • (Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE.) Transplant Cell Ther. 2024 Sep;30(9):917.e1-917.e12 PMID: 38944153 PMCID: PMC11587342 SCOPUS ID: 2-s2.0-85199289175 06/30/2024

  • (Furqan F, Bhatlapenumarthi V, Dhakal B, Fenske TS, Farrukh F, Longo W, Akhtar O, D'Souza A, Pasquini M, Guru Murthy GS, Runaas L, Abedin S, Mohan M, Shah NN, Hamadani M.) Blood Adv. 2024 Aug 27;8(16):4320-4329 PMID: 38889435 PMCID: PMC11372811 SCOPUS ID: 2-s2.0-85203009004 06/18/2024

  • (Pasquini MC, Wallace PK, Logan B, Kaur M, Tario JD, Howard A, Zhang Y, Brunstein C, Efebera Y, Geller N, Giralt S, Hari P, Horowitz MM, Koreth J, Krishnan A, Landau H, Somlo G, Shah N, Stadtmauer E, Vogl DT, Vesole DH, McCarthy PL, Hahn T.) J Clin Oncol. 2024 Aug 10;42(23):2757-2768 PMID: 38701390 PMCID: PMC11634105 SCOPUS ID: 2-s2.0-85201029574 05/03/2024

  • (Vadgama S, Pasquini MC, Maziarz RT, Hu ZH, Ray M, Smith H, Bullement A, Edmondson-Jones M, Sullivan W, Cartron G.) Blood Adv. 2024 Jul 09;8(13):3519-3527 PMID: 38662645 PMCID: PMC11261112 SCOPUS ID: 2-s2.0-85198138125 04/25/2024

  • (Locke FL, Siddiqi T, Jacobson CA, Ghobadi A, Ahmed S, Miklos DB, Perales MA, Munoz J, Fingrut WB, Pennisi M, Gauthier J, Shadman M, Gowda L, Mirza AS, Abid MB, Hong S, Majhail NS, Kharfan-Dabaja MA, Khurana A, Badar T, Lin Y, Bennani NN, Herr MM, Hu ZH, Wang HL, Baer A, Baro E, Miao H, Spooner C, Xu H, Pasquini MC.) Blood. 2024 Jun 27;143(26):2722-2734 PMID: 38635762 PMCID: PMC11251200 SCOPUS ID: 2-s2.0-85193847404 04/18/2024

  • (Gagelmann N, Bishop M, Ayuk F, Bethge W, Glass B, Sureda A, Pasquini MC, Kröger N.) Transplant Cell Ther. 2024 Jun;30(6):584.e1-584.e13 PMID: 38281590 SCOPUS ID: 2-s2.0-85187506193 01/29/2024

  • (Lunning MA, Wang HL, Hu ZH, Locke FL, Siddiqi T, Jacobson CA, Ahmed S, Miklos DB, Lin Y, Hill BT, Ghobadi A, Neelapu SS, Westin J, Dieyi C, Field P, Miao H, Shahani SA, Patel A, Spooner C, Fu C, Muramoto D, Xu H, Pasquini MC.) Am J Hematol. 2024 May;99(5):880-889 PMID: 38504387 SCOPUS ID: 2-s2.0-85188568576 03/20/2024

  • (Brazauskas R, Flynn K, Krishnan A, Landau H, Giralt S, Pasquini MC, Stadtmauer EA, D'Souza A.) Br J Haematol. 2024 Apr;204(4):1429-1438 PMID: 38348544 PMCID: PMC11006567 SCOPUS ID: 2-s2.0-85185482209 02/13/2024

  • (Levine BL, Pasquini MC, Connolly JE, Porter DL, Gustafson MP, Boelens JJ, Horwitz EM, Grupp SA, Maus MV, Locke FL, Ciceri F, Ruggeri A, Snowden J, Heslop HE, Mackall CL, June CH, Sureda AM, Perales MA.) Nat Med. 2024 Feb;30(2):338-341 PMID: 38195751 SCOPUS ID: 2-s2.0-85181956361 01/10/2024

  • (Baldomero H, Neumann D, Hamad N, Atsuta Y, Sureda A, Iida M, Karduss A, Elhaddad AM, Bazuaye NG, Bonfim C, Camara Rdl, Chaudhri NA, Ciceri F, Correa C, Frutos C, Galeano S, Garderet L, Greco R, Jaimovich G, Kodera Y, Koh MB, Liu K, Ljungman P, McLornan DP, Nair G, Okamoto S, Pasquini MC, Passweg J, Paulson K, Ruggeri A, Seber A, Snowden JA, Srivastava A, Worel N, Saber W, Rondelli D, Aljurf M, Niederwieser D.) Best Practice and Research: Clinical Haematology. June 2024;37(2) SCOPUS ID: 2-s2.0-85199185606 06/01/2024

Publications of from the

© 2024 皇家华人.  All rights reserved.  | Terms and Privacy 

Non-Discrimination Statement
The 皇家华人 (MCW) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, or military status. Employees, students, applicants or other members of the MCW community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic. MCW’s policy as well as federal and state laws and regulations prohibit unlawful discrimination and harassment.